A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.

The Lancet regional health. Western Pacific(2023)

引用 3|浏览11
暂无评分
摘要
New Terrain Biotechnology, Inc., Tianjin, China.
更多
查看译文
关键词
myasthenia gravis,autoantibody diagnostic assays,double-blind
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要